Sanofi
Atopic dermatitis, aka eczema, affects more than 10% of Americans of all ages. It’s characterized by inflammation that causes dry, itchy patches on the skin. Though not life-threatening, it can be a painful nuisance and lead to dermal infections. According to a recent Everyday Health article, the FDA just approved the first biologic intended to treat the condition in kids ages 6 months to 5 years.
The drug, Sanofi’s Dupixent, is administered as a monthly injection under the skin at different sites. More than half the kids who participated in the drug’s trial saw a 75% reduction in the severity of the disease.
